Welcome

AROMICS is a biotech company committed to the discovery and development of novel drugs and diagnostic methods to target relevant human diseases and improve patient’s quality of life.

We believe that OMIC technologies represent an important first step towards gaining biological insights into:

  • How drugs work, giving them added value, reducing attrition rates and advancing  through the clinic.
  • Determining clinically predictive molecular endpoints that help physicians manage the disease, drive prescriptions and monitor drug response.

Events

10/09/2024 | BioJapan
BIOJAPAN is the Asia's largest partnering event consisting of Exhibition,... More

10/07/2024 | EU-Japan Biotech-Pharma Partnering Conference 2024
The EU-Japan Biotech & Pharma Partnering Conference 2024 offers business... More

News

10/18/2024 | AROMICS participates in BIOJAPAN
Aromics participated in BioJapan, the benchmark fair in the sector... More

10/12/2024 | The EU-Japan Biotech & Pharma Partnering Conference 2024
Aromics and our CEO Dr. Plasencia, presented latest advances of the company... More